190 related articles for article (PubMed ID: 33513243)
1. Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
Binder G; Nakamura A; Schweizer R; Ogata T; Fukami M; Nagasaki K
J Clin Endocrinol Metab; 2021 Apr; 106(5):1491-1500. PubMed ID: 33513243
[TBL] [Abstract][Full Text] [Related]
2. Aromatase excess syndrome in a Chinese boy due to a novel duplication at 15q21.2.
Tan X; Wu X; Chen J; Wu Y; Li S; Chen X; Zhang X
J Pediatr Endocrinol Metab; 2019 Jan; 32(1):85-88. PubMed ID: 30530883
[TBL] [Abstract][Full Text] [Related]
3. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
[TBL] [Abstract][Full Text] [Related]
4. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
[TBL] [Abstract][Full Text] [Related]
5. Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression.
Fukami M; Tsuchiya T; Vollbach H; Brown KA; Abe S; Ohtsu S; Wabitsch M; Burger H; Simpson ER; Umezawa A; Shihara D; Nakabayashi K; Bulun SE; Shozu M; Ogata T
J Clin Endocrinol Metab; 2013 Dec; 98(12):E2013-21. PubMed ID: 24064691
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
[TBL] [Abstract][Full Text] [Related]
7. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
Verma N; Jain V; Birla S; Jain R; Sharma A
J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
[TBL] [Abstract][Full Text] [Related]
8. Aromatase deficiency, a rare syndrome: case report.
Baykan EK; Erdoğan M; Özen S; Darcan Ş; Saygılı LF
J Clin Res Pediatr Endocrinol; 2013; 5(2):129-32. PubMed ID: 23748068
[TBL] [Abstract][Full Text] [Related]
9. Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.
Chen Z; Wang O; Nie M; Elison K; Zhou D; Li M; Jiang Y; Xia W; Meng X; Chen S; Xing X
Mol Cell Endocrinol; 2015 Jan; 399():32-42. PubMed ID: 25301327
[TBL] [Abstract][Full Text] [Related]
10. Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age.
Crocker MK; Gourgari E; Lodish M; Stratakis CA
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2673-80. PubMed ID: 25226294
[TBL] [Abstract][Full Text] [Related]
11. Local aromatase excess with recruitment of unusual promoters of
Deberles E; Durand I; Mittre H; Reznik Y; Morera J
J Pediatr Endocrinol Metab; 2022 Jul; 35(7):924-930. PubMed ID: 35667691
[TBL] [Abstract][Full Text] [Related]
12. Anastrozole monotherapy further improves near-adult height after the initial combined treatment with leuprorelin and anastrozole in early-maturing girls with compromised growth prediction: results from the second phase of the GAIL study.
Papadimitriou DT; Dermitzaki E; Christopoulos P; Livadas S; Grivea IN; Mastorakos G
Front Endocrinol (Lausanne); 2024; 15():1366970. PubMed ID: 38628587
[TBL] [Abstract][Full Text] [Related]
13. Aromatase deficiency in a male patient - Case report and review of the literature.
Miedlich SU; Karamooz N; Hammes SR
Bone; 2016 Dec; 93():181-186. PubMed ID: 27693882
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors in pediatrics.
Wit JM; Hero M; Nunez SB
Nat Rev Endocrinol; 2011 Oct; 8(3):135-47. PubMed ID: 22024975
[TBL] [Abstract][Full Text] [Related]
15. Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants.
Fukami M; Shozu M; Soneda S; Kato F; Inagaki A; Takagi H; Hanaki K; Kanzaki S; Ohyama K; Sano T; Nishigaki T; Yokoya S; Binder G; Horikawa R; Ogata T
J Clin Endocrinol Metab; 2011 Jun; 96(6):E1035-43. PubMed ID: 21470988
[TBL] [Abstract][Full Text] [Related]
16. Prepubertal gynaecomastia in a boy with Peutz-Jeghers syndrome: managing the aromatase overexpression.
Simões-Pereira J; Santos F; Lopes L; Limbert C
J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1149-1154. PubMed ID: 30052520
[TBL] [Abstract][Full Text] [Related]
17. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
18. Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the
Özen S; Atik T; Korkmaz Ö; Onay H; Gökşen D; Özkınay F; Çoğulu Ö; Darcan Ş
J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):109-112. PubMed ID: 30968679
[TBL] [Abstract][Full Text] [Related]
19. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
20. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.
Janner M; Flück CE; Mullis PE
Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
